SimPath Licenses Novel ORNL System for Enhanced Synthetic Biology (1 of 3) (IMAGE)
Caption
Michelle Buchanan, deputy for science and technology at Oak Ridge National Laboratory, and Robert Moseley and Ben Mohr of SimPath signed an agreement for SimPath to license a novel ORNL cloning system that assembles the biological building blocks necessary to synthetically bioengineer new medicines and fuels.
Credit
Jason Richards/Oak Ridge National Laboratory, US Department of Energy
Usage Restrictions
None
License
Licensed content